Workstreams

MMIP is divided into six workstreams, each working towards achieving the outcome of an internationally recognised, attractive and thriving environment for medicines manufacturing. All of these workstreams are supported by overarching communications work and building the manufacturing community to ensure it speaks with one voice.

Regulatory Environment

The regulatory environment workstream is trying to maximise innovative processes by highlighting existing regulatory flexibility and the positive UK regulatory landscape to industry.

One of the ways it is doing this is by partnering with the Medicines and Healthcare Products Regulatory Agency (MHRA) to produce case studies on regulatory collaboration between medicines manufacturers and the MHRA Innovation Office. Further details on the MHRA Innovation Office and the case studies can be found here.

Skills

The skills workstream aims to foster a sustainable medicines manufacturing workforce and appropriate skills to support the growth of medicines manufacturing in the UK.

Science Industry Partnership (SIP)

MMIP supports the Science Industry Partnership (SIP), which is co-funded by government and industry to develop a strategy for near term and future skills provision in the life sciences sector.

As part of this work, MMIP and the ABPI undertook a skills survey to provide information on skills need for the manufacture of medicines. These findings were discussed with Cogent, the UK’s strategic body for skills in the science industries, before being presented to the SIP and helped to secure £52m of investment in new and emerging science talent.

Following this work, the Life Sciences Sector Deal, Phase 2, a key output from the Government’s Industrial Strategy  announced last year, includes the development of a Life Sciences 2030 Skills Strategy. The Science Industry Partnership, with key partners including; Government, The Association of the British Pharmaceutical Industry (ABPI) and the BioIndustry Association (BIA), lead and deliver this Skills Strategy. The Medicines Manufacturing Industry Partnership (MMIP) are fully supportive of this piece of work and welcome the recognition that Medicines Manufacture forms a distinct and significant component of the assessment.

 

Alex Felthouse, a Board Member of the SIP and a member of the MMIP Leadership team will lead the 2030 Strategy development.

 

Advanced Therapies manufacturing Taskforce

Advanced Therapies Manufacturing Taskforce Action Plan outlines a strategy on how the UK can become the global hub of advanced medicinal therapy manufacturing and ensure the long-term success of this industry in the UK.

One recommendation from the Action Plan was the creation and implementation of an end-to-end talent plan for the sector which encompasses integrated strategies to develop the talent pool at multiple entry-points, ranging from Manufacturing Technicians through to Post-doctoral and Professional levels. The Gatsby Foundation, with its interest in technical training, funded work to investigate how to create a technician workforce,  culminating in an AT Manufacturing Apprenticeship event at GSK Stevenage during National Apprenticeship week (#NAW18)! Potential and current employers joined apprentices, training providers, funders and accrediting bodies to explore the benefits of apprenticeships within AT Manufacturing, where information was provided on the latest developments in delivery from the Institute for Apprenticeships (IfA) and suitable apprenticeship programmes identified within the sector.

Following the event, Innovate UK announced a £1.5m investment in AT Manufacturing Apprenticeships - see here for the report from the Gatsby funded work, Advanced Therapies Manufacturing Apprenticeships blog, Apprenticeship Guideline booklet from the event and Cell and Gene Therapy Catapult press release

 

To help understand how apprentiships and academic learning align, take a look at the career path options schematic below

Apprenticeships are growing in popularity in the medicines manufacturing sector - learn more from the GSK case studies.

Cogent have published some useful guides to employing apprentices and work experience students 

Over 300 Industry leaders from 160 leading organisations met in Cardiff last year at the 14th Annual bioProcessUK Conference. Top of the agenda, which focused on the latest news, updates and developments within the manufacturing and biologics arena, was the topic of skills, highlighted by many as one of the key drivers in building a stronger UK medicines manufacturing basis. Read the blog here:

Fiscal environment

The fiscal environment workstream focuses on developing fiscal incentives to encourage a more competitive environment for medicines manufacturing in the UK.

This includes a briefing paper on the fiscal benefits of establishing and retaining medicine manufacture in the UK and a position paper on fiscal incentives

Technology and Innovation

The Technology and Innovation workstream seeks to understand and pursue the future needs of the medicines manufacturing industry.

Working with government agencies and academia, MMIP are identifying novel manufacturing technology areas, opportunities for their development and introduction in the UK and ways of facilitating this.

MMIP is putting resources towards a Medicines Manufacturing Innovation Centre, this aims to catalyse the implementation of new technology in both the pharmaceutical and fine chemical supply chains. 

MMIP launched its Technology and Innovation Road Map in August 2016. This makes recommendations to protect and grow UK medicines manufacturing in order to maintain the UK’s leading position in an increasingly competitive global landscape. Specifically, it calls for strategic investment in complementary technology centres, funded through the Industrial Strategy Challenge Fund.

 

Advanced therapies manufacturing

The advanced therapies manufacturing workstream seeks to ensure delivery the recommendations of the Advanced Therapies Manufacturing Taskforce Action Plan which outlines a strategy on how the UK can become the global hub of advanced medicinal therapy manufacturing and ensure the long-term success of this industry in the UK. The transition of the Taskforce to "business as usual" was presented at the 2017 bioProcessUK Conference.

See the Taskforce press releases here 

One recommendation from the Action Plan was the creation and implementation of an end-to-end talent plan for the sector which encompasses integrated strategies to develop the talent pool at multiple entry-points, ranging from Manufacturing Technicians through to Post-doctoral and Professional levels. The Gatsby Foundation, with its interest in technical training, funded work to investigate how to create a technician workforce,  culminating in an AT Manufacturing Apprenticeship event at GSK Stevenage during National Apprenticeship week (#NAW18)! Potential and current employers joined apprentices, training providers, funders and accrediting bodies to explore the benefits of apprenticeships within AT Manufacturing, where information was provided on the latest developments in delivery from the Institute for Apprenticeships (IfA) and suitable apprenticeship programmes identified within the sector. Following the event, Innovate UK announced a £1.5m investment in AT Manufacturing Apprenticeships - see here for the report from the Gatsby funded work, Advanced Therapies Manufacturing Apprenticeships blog, Apprenticeship Guideline booklet from the event and Cell and Gene Therapy Catapult press release